SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : CORX: Nasdaq... gets broad patent for Alzheimer drug!! -- Ignore unavailable to you. Want to Upgrade?


To: Arizona997 who wrote (11)12/6/1998 5:29:00 PM
From: j g cordes  Respond to of 13
 
Gee Gary, you're digging too deep, lighten up. I am looking for an answer to the question exactly as I phrased it. You are wrong on all three counts, I'm not in the stock, haven't sold it, never knew about it before a news scan late last week. The Yahoo article on CORX's fight to stay listed is what I'm trying to get answer's to.

"Friday November 13, 11:59 pm Eastern Time

Cortex Pharmaceutical faces delisting

IRVINE, Calif., Nov. 13 (Reuters) - Cortex Pharmaceuticals Inc
on Friday said the Nasdaq stock market has issued a notice to delist the company's stock from its smallcap market, and the company has requested a hearing on the matter.

In a statement, the drug development company said a hearing is expected in late December or early January, though no date has been set.

Cortex said the notice of delisting was prompted by the company's inability to comply with Nasdaq rules for listing.

Those rules require net tangible assets of $2 million, market capitalization of $35 million or net income of at least $500,000 in the most recently completed fiscal year or in two of three most
recently completed fiscal years, Cortex said."

As to your "positive" attitude on the stock and the company lifting mankind's suffering.. good luck, BUT next time just try answering the question or contributing instead of trying to second guess the motive.